Value-based medicine in ophthalmology;"Value-based medicine" in der augenheilkunde

Ophthalmologe

Volumn 103, Issue 6, 2006, Pages 493-500

  Hirneiss C ^a   Neubauer, A S ^a   Tribus, C ^a   Kampik, A ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cost utility analysis; Ophthalmology; Time trade off; Value based medicine

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; EYE CARE; HEALTH CARE COST; HUMAN; OPHTHALMOLOGY; QUALITY OF LIFE;

EID: 33745145876     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-006-1340-9     Document Type: Article

References (37)

1. Brown CG (1999) Vision and quality-of-life. Trans Am Ophthalmol Soc 97: 473-511
2. Brown GC, Brown MM, Sharma S et al. (1999a) Cost-effectiveness of treatment for threshold retinopathy of prematury. Paediatrics 104: 47
3. Brown GC, Brown MM, Sharma S et al. (2000) Incremental cost-effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 107: 1374-1380
4. Brown GC, Sharma S, Brown MM et al. (2000) Difference between ophthalmologists' and patients' perceptions of quality of life associated with age related macular degeneration. Can J Ophthalmol 35: 127-133
5. Brown MM, Brown GC, Sharma S et al. (1999b) Evidence based medicine, utilities, and quality of life. Curr Opin Ophthalmol 10: 221-226
6. Brown MM, Brown GC, Sharma S et al. (2001) Quality of life associated with unilateral and bilateral good vision. Ophthalmology 108: 543-547
7. Brown MM, Brown GC, Sharma S et al. (2003) Health care economic analyses and value-based medicine. Surv Ophthalmol 48: 204-223
8. Busbee BG, Brown MM, Brown, GC (2002) Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 109: 606-612
9. Busbee BG, Brown MM, Brown GC et al. (2003) Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 110: 2310-2317
10. Cheng AK, Rubin HR, Powe NR et al. (2000) Cost-utility analysis of the cochlear implant in children. JAMA 284: 850-856
11. Detsky AS, Naglie G, Krahn MD (1997) Primer on medical decision analysis; Part 1 Getting started. Part 2 Building a tree. Med Decis Making 17: 123-135
12. nd en. Oxford University Pres, New York
13. Ebell MH, Warbasse L, Brenner C (1997) Evaluation of the dyspeptic patients: a cost-utility study. J Fam Pract 44: 545-555
14. Hayman JA, Hillner BE, Harris JR et al. (1998) Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. J Clin Oncol 16: 1022-1029
15. Hirneiss C, Neubauer AS, Welge-Luessen U et al. (2003) Bestimmung der Lebensqualität des Patienten in der Augenheilkunde. Ophthalmologe 100: 1091-1097
16. Hirneiss C, Rombold F, Kampik A, Neubauer AS (2005) Visual quality of life after vitreoretinal surgery for epiretinal membranes. Ophthalmologe (Epub ahead of print)
17. Hirth RA, Chernew ME, Miller E et al. (2000) Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard. Med Decis Making 20: 332-342
18. Hollands H, Lam M, Pater J et al. (2001) Reliability of the time-trade-off technique of utility assessment in patients with retinal disease. Can J Ophthalmol 36: 202-209
19. Hopley C, Salkeld G, Mitchell P (2004) Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration. Br J Ophthalmol 88: 982-987
20. Hopley C, Salkeld G, Wang JJ, Mitchell P (2004) Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants. Br J Ophthalmol 88: 450-454
21. Klarmann H, Francis J, Rosenthal, G (1968) Cost-effectiveness applied to the treatment of chronic renal disease. Med Care 6: 48-55
22. König HH, Barry JC (2004) Cost effectiveness of treatment for ambloypia: an analysis based on a probabilistic Markov model. Br J Ophthalmol 88: 606-612
23. Lacey LA, Wolf A, O'shea D et al. (2005) Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland. Int J Obes Relat Metabol Disord (im Druck)
24. Laupacis A, Feeny D, Detsky AS et al. (1992) How attractive does a new technology have to be to warrant adoption and utilizytion? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 146: 473-481
25. Mangione, CM, Berry, S, Spritzer, K (1998) Identifying the content area for the 51-item National Eye Institut Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116: 227-233
26. Mushlin AI, Mooney C, Holloway RG (1997) The cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms. Int J Technol Assess Health Care 13: 21-34
27. Neubauer AS, Neubauer S (2005) Kosteneffektivität von Screening auf Amblyopie. Klin Monatsbl Augenheilkd 222: 1-7
28. nd en. Churchill Livingstone, Philadelphia, pp 1-12
29. Samsa GP, Matchar DB, Goldstein L et al. (1998) Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J 136: 703-713
30. Sendi PP, Bucher HC, Steurer J (1998) Kritische Beurteilung einer Kosteneffektivitäts-Analyse. Praxis 1998, Verlag Hans Huber, Bern. 87: 1695: 1702
31. Sharma S, Brown GC, Brown MM et al. (2002) Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients. Br J Ophthalmol 86: 493-496
32. Sharma S, Brown GC, Brown MM et al. (2001) The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 108: 2051-2059
33. Stein JD (2004) Disparities between ophthalmologists and their patients in estimating quality of life. Curr Opin Ophthalmol 15: 238-243
34. Steinberg, EP, Tielsch, JM, Schein, OD et al (1994) The VF-14: an index of functional impairment in cataract patients. Arch Ophthalmol 112: 630-638
35. Torrance GW, Feeny D. (1989) Utilities and Quality-adjusted life years. Intl. J. of Technology Assessment in Health Care 5: 559-575
36. Velasco M et al. (2002) Best practice in undertaking and reporting HTA Int J Technol Assess Health Care 18: 321-422
37. Weinstein MC, Siegel JE, Gold MR et al. (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276: 1253-1258